AIGH Capital Management »

Esperion Therapeutics shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.0M 3.0M 2.65

More positions owned by AIGH Capital Management

Zevra Therapeutics Com New (ZVRA)
Sandisk Corp (SNDK)
Personalis Ord (PSNL)
Domo Com Cl B (DOMO)
Advanced Emissions (ARQ)
MaxLinear (MXL)
Nlight (LASR)
Castle Biosciences (CSTL)
Lumen Technologies (LUMN)
Day One Biopharmaceuticals I (DAWN)
Digital Turbine Com New (APPS)
Bk Technologies Corporation Com New (BKTI)
Vishay Precision (VPG)
Esperion Therapeutics (ESPR)
Lightpath Technologies Com Cl A (LPTH)

View all positions for AIGH Capital Management

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics